Clinical Data Beam posts positive data on base editing treatment for AATD BioPharma DiveUpdated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.Clinical DataRare DiseaseRead full story pharminent March 25, 2026 (Last updated: March 26, 2026) BioPharma Dive Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study. Clinical DataRare DiseaseRead full story Post navigation Previous: Sarepta sees early success with RNAi drugs from ArrowheadNext: Maze tumbles despite positive data for kidney disease drug Related Stories Clinical Data BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival pharminent May 12, 2026 Clinical Data Novo says high-dose Wegovy can cause 28% weight loss pharminent May 12, 2026 Clinical Data Pulsesight reports positive phase 1 data for PST611 in dry AMD pharminent May 11, 2026
